Global mRNA Vaccines and Therapeutics Market is valued at approximately USD 46.8 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 16.5% over the forecast period ...

The Committee for Medicinal Products for Human Use recommends marketing authorization for Pfizer and BioNTech's updated ...

A Navy SEAL unit is busy preparing for a Chinese invasion of Taiwan, the Financial Times said. It may be training Taiwan's forces to fight back against Chinese forces, retired Navy officers told BI.

William Lai Ching-te’s first 100 days as leader of Taiwan have been evaluated not only on the basis of his handling of local affairs, but also in relation to the self-governed island’s ...

A ranking of the top songs based on streaming and sales activity from within the country- as tracked by Luminate. The ranking is based on a weighted formula incorporating official-only streams ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.

UBS analyst Eliana Merle maintained a Hold rating on BioNTech SE (BNTX – Research Report) today and set a price target of $131.00. The company’s shares opened today at $121.40. According to ...

mRNA specialist BioNTech has chalked up an important win in its cancer pipeline, showing efficacy with its BNT111 vaccine candidate in a phase 2 trial in advanced melanoma. The study is looking at ...

Pfizer and BioNTech have been among the leaders in the race to bring a combined COVID-19 and influenza vaccine to market, but have stumbled in the final straight. The companies reported mixed ...

The Dow Jones, S&P 500 and Nasdaq struggled to stay positive Tuesday morning. Palantir stock took a break on the stock market today.

005930.KS Samsung Electronics Co., Ltd.